Literature DB >> 3281843

Role of gastrin and cholecystokinin in tumours of the gastrointestinal tract.

C B Lamers1, J B Jansen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3281843     DOI： 10.1016/0277-5379(88)90264-7

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN： 0277-5379


× No keyword cloud information.
  8 in total

Review 1.  Hormonal control of gastric and colorectal cancer in man.

Authors:  D L Morris; S A Watson; L G Durrant; J D Harrison
Journal:  Gut       Date:  1989-04       Impact factor: 23.059

2.  Growth-promoting effects of gastrin on mouse colon cancer cells in vitro: absence of autocrine effects.

Authors:  Y S Guo; M Baijal; G F Jin; J C Thompson; C M Townsend; P Singh
Journal:  In Vitro Cell Dev Biol       Date:  1990-09

Review 3.  On the role of cholecystokinin in pancreatic cancer.

Authors:  M K Herrington; T E Adrian
Journal:  Int J Pancreatol       Date:  1995-04

4.  Gastrin and colorectal cancer. Evidence against an association.

Authors:  R Yapp; I M Modlin; R R Kumar; H J Binder; R Dubrow
Journal:  Dig Dis Sci       Date:  1992-04       Impact factor: 3.199

5.  Gastrointestinal hormone mRNA expression in human colonic adenocarcinomas, hepatic metastases and cell lines.

Authors:  G Monges; P Biagini; J F Cantaloube; P De Micco; D Parriaux; J F Seitz; J R Delpero; J Hassoun
Journal:  Clin Mol Pathol       Date:  1996-06

Review 6.  Effects of hypochlorhydria and hypergastrinemia on structure and function of gastrointestinal cells. A review and analysis.

Authors:  J W Freston; K Borch; S J Brand; E Carlsson; W Creutzfeldt; R Håkanson; L Olbe; E Solcia; J H Walsh; M M Wolfe
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

Review 7.  Neuropeptide growth factors and cancer.

Authors:  P J Woll
Journal:  Br J Cancer       Date:  1991-03       Impact factor: 7.640

8.  Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects.

Authors:  J G Klijn; A M Hoff; A S Planting; J Verweij; T Kok; S W Lamberts; H Portengen; J A Foekens
Journal:  Br J Cancer       Date:  1990-10       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.